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EDITORIAL
At each of the World Congresses, three members of the Scientific Programme Committee are asked
to review and summarize the meeting in the three major topic areas of pancreas, biliary and liver. At
the Washington World Congress (May 2004), the honour for summarizing the pancreas and biliary
presentations fell to Professor Roland Andersson of Lund, Sweden, and Dr Lilian Kow of Adelaide,
Australia, who respectively reviewed the pancreas and biliary presentations.
As a prelude to this issue ofHPBwhich highlights the pancreas and biliary scientific work presented at
the Washington World Congress, their respective summaries are included below.
I thank Roland and Lilian for their superb contribution, as I thank all of those who submitted their
work for publication in HPB – I present to you in this issue of HPB the best of the best in the pancreas
and biliary programme of the Washington Congress.
Jim Toouli
Editor-in-Chief
PANCREAS SUMMARY
The pancreas sessions during the 6th World Congress
of the IHPBA in Washington were well attended and
covered many of the questions and controversies that
exist in pancreatology. Free papers and posters,
symposia, updates, debates and keynote lectures
covered acute and chronic pancreatitis as well as topics
related to pancreatic tumours.
In the symposia the following topics were
discussed.
Necrotizing pancreatitis. The ideal marker for
severity assessment does not exist. However, scoring
with APACHE II is probably the best overall and
C-reactive protein (CRP) determination the best
single marker. Computed tomography (CT) is a late
denominator. The dynamics of multiple organ dys-
function are important. Enteral nutrition is feasible,
probably of benefit and could potentially be adminis-
tered nasogastrically. The value of various supple-
ments is still to be proven. Surgery should be
performed on proper indications and timing (late) and
minimal invasive methods are under development.
Intraductal papillary mucinous tumours and
mucinous cystic neoplasms of the pancreas are
different entities and premalignant with potential
progression to invasive cancer. Resection should be
tailored according to pathology with an attempt to
preserve function. First-line lymph nodes should be
resected.
Pancreatic tumours were discussed and an algo-
rithm for staging including CT, potentially endoscopic
ultrasound and laparoscopy was presented. Vascular
resection is feasible and could be justified in resection
with radical attempt. Extended pancreaticoduode-
nectomy could not be indicated, while extended lymph
node “sampling” could potentially be of value for
tailoring future adjuvant chemotherapy.
Free papers and posters on acute pancreatitis high-
lighted the following.
Disturbances in microcirculation and concomitant
ischaemia and reperfusion injury represent central
mechanisms, where blocking of galanin, a vasoactive
neuropeptide, as well as the use of hypertonic saline
solution, was effective (1346, 1347, 1354). Gut barrier
failure and translocation of bacteria decreased by the
use of the tumour necrosis factor (TNF) inhibitor
pentoxifylline (1352). Antibiotic penetration (piper-
acycline/tazobactam) was effective in the necrotic
pancreas (O203).No increase over time was seen in the
incidence of fungal colonization of necrotizing
pancreatitis despite the use of antibiotic prophylaxis
(1351).
APACHE II as evaluated after 48 h was better than
Ranson in predicting severity in acute pancreatitis
(209). Necrotizing acute pancreatitis is still associated
with substantial mortality (210, 1353). Endoscopic
sphincterotomy within 48–72 h and laparoscopic
cholecystectomy within 8–10 days were recommended
in acute biliary pancreatitis (1358). The overall trend is
towards more conservative management (1353, 1355);
complications following necrosectomy are still
frequent and potentially life-threatening (1349).
Future treatment may include immunomodulation
and several experimental studies demonstrated the
benefits of, for example, inhibition of NFkB (202),
antioxidants (204), or EPA (omega-3 fatty acids),
resulting in a down-regulation of the inflammatory
response and a decrease in both pancreatic and
pulmonary injury.
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